样式: 排序: IF: - GO 导出 标记为已读
-
US Renal Data System 2023 Annual Data Report: Epidemiology of Kidney Disease in the United States Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-03-20 Kirsten L. Johansen, David T. Gilbertson, Shuling Li, Suying Li, Jiannong Liu, Nicholas S. Roetker, Elaine Ku, Ivonne H. Schulman, Raquel C. Greer, Kevin Chan, Kevin C. Abbott, Catherine R. Butler, Ann M. O’Hare, Neil R. Powe, Yuvaram N.V. Reddy, Jon Snyder, Wendy St. Peter, Janelle S. Taylor, Eric D. Weinhandl, James B. Wetmore
-
Clinical Significance of the Cystic Phenotype in Alport Syndrome Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-03-19 Letizia Zeni (MD PhD), Federica Mescia (MD), Diego Toso (MD), Chiara Dordoni (MD), Cinzia Mazza (MD PhD), Gianfranco Savoldi (MD PhD), Laura Econimo (MD), Roberta Cortinovis (MD), Simona Fisogni (MD), Federico Alberici (MD PhD), Francesco Scolari (MD), Claudia Izzi (MD)
Alport Syndrome (AS) is the most common genetic glomerular disease caused by mutations that affect Type IV collagen. However, the clinical characteristics and significance of AS with kidney cysts are not well defined. This study investigated the prevalence and clinical significance of cystic kidney phenotype in AS. Retrospective cohort study. & Participants: One hundred-eight patients with AS and a
-
2024 Update on Classification, Etiology, and Typing of Renal Amyloidosis Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-03-19 Nelson Leung M.D., Samih H. Nasr M.D.
Amyloidosis is a protein folding disease that causes organ injuries and even death. In humans, 42 proteins are now known to cause amyloidosis. Some proteins become amyloidogenic as a result of a pathogenic variant as seen in hereditary amyloidoses. In acquired forms of amyloidosis, the proteins form amyloid in their wild-type state. Four types (serum amyloid A (AA), transthyretin (ATTR), apolipoprotein
-
Urine Albumin-Creatinine Ratio Variability in People With Type 2 Diabetes: Clinical and Research Implications Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-03-15 Natasha Rasaratnam, Agus Salim, Irene Blackberry, Mark E. Cooper, Dianna J. Magliano, Peter van Wijngaarden, Suresh Varadarajan, Julian W. Sacre, Jonathan E. Shaw
Evidence has demonstrated that albuminuria is a key diagnostic and prognostic marker of diabetic chronic kidney disease, but the impact of its day-to-day variability has not been adequately considered. This study quantified within-individual variability of albuminuria in people with type 2 diabetes to inform clinical albuminuria monitoring. Descriptive cross-sectional analysis. People with type 2 diabetes
-
Anti–Glomerular Basement Membrane Disease: Broadening the Spectrum Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-03-15 Lynn D. Cornell
-
Trajectories of Physical Resilience Among Older Veterans With Stage 4 CKD Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-03-12 C. Barrett Bowling MD MSPH, Theodore S.Z. Berkowitz MS, Brett T. Burrows PhD, Jessica E. Ma MD, Heather E. Whitson MD MHS, Battista Smith MPH, Steven D. Crowley MD, Virginia Wang PhD, Matthew L. Maciejewski PhD, Maren K. Olsen PhD
Although functional impairment is common among older adults with chronic kidney disease (CKD), functional reserve before an acute health event and physical resilience after have not been characterized in this population. The purpose of this study was to identify distinct patterns of physical function before and after an acute health event among older Veterans with Stage 4 CKD. Prospective cohort study
-
Hereditary Transthyretin Amyloidosis: Impact of Classic and New Treatments on Kidney Function Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-03-12 Evelyn Meléndrez-Balcázar BM, Karla Aranda-Vela BM, Alberto Cervantes-Hernández BM, Samuel López-Cureño BM
Hereditary transthyretin amyloidosis (ATTRv) is a rare, progressive, and life-threatening disease caused by misfolded transthyretin (TTR) proteins that aggregate as abnormal amyloid fibrils and accumulate throughout the body. The kidney is one of the main organs affected in amyloid light chain (AL) amyloidosis and ATTRv amyloidosis. The most common clinical presentation is proteinuria, which consists
-
EKFC Versus CKD-EPI Equation in Young Adults? No Definitive Answer Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-03-12 Pierre Delanaye MD PhD, Hans Pottel PhD
-
Gestational Exposure to Maternal Systemic Glucocorticoids and Childhood Risk of CKD Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-03-11 You-Lin Tain, Lung-Chih Li, Hsiao-Ching Kuo, Chien-Ning Hsu
The potential effects of antenatal glucocorticoid exposure on the health of children are unclear. We examined the association of gestational exposure to maternal systemic glucocorticoids (SG) and the risk of developing chronic kidney disease (CKD) in childhood. Retrospective cohort study. Newborns cared for at the largest healthcare delivery system in Taiwan between 2004 and 2018. Maternal prescriptions
-
Thiazides for Nephrolithiasis Prevention: Written in Stone? Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-03-08 Anna L. Zisman MD
-
Urinary Plasminogen as a Marker of Disease Progression in Human Glomerular Disease Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-03-05 Marina de Cos, Gohar Mosoyan, Kinsuk Chauhan, Jonathan P. Troost, Jenny S. Wong, Sean Lefferts, Paul Morgan, Kristin Meliambro, Marc Egerman, Justina Ray, Tom Parker, Daniel Levine, Surya Seshan, Yoni Bardash, Benjamin Horowitz, Candice A. Kent, Melissa M. Shaw, Alan Perlman, Dennis G. Moledina, Steven G. Coca, Kirk N. Campbell
-
Enhancing Kidney Transplantation and the Role of Xenografts: Report of a Scientific Workshop Sponsored by the National Kidney Foundation Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-03-05 Andrew B. Adams, Emily A. Blumberg, John S. Gill, Eliezer Katz, Tatsuo Kawai, Jesse D. Schold, Megan Sykes, Alfred Tector, David H. Sachs
Chronic kidney disease affects an estimated 37 million people in the United States; of these,>800,000 have end-stage renal disease requiring chronic dialysis or a kidney transplant to survive. Despite efforts to increase the donor kidney supply, approximately 100,000 people are registered on the kidney transplant wait-list with no measurable decrease over the past 2 decades. The outcomes of kidney
-
Residential Racial and Ethnic Segregation and Post–Kidney Transplant Dementia, Allograft Loss, and Mortality Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-03-04 Yusi Chen MHS, Yiting Li MPH, Yi Liu ScM, Byoungjun Kim PhD, Jessica M. Ruck MD, Maya N. Clark-Cutaia PhD ACNP-BC, Aarti Mathur MD PhD, Tanjala S. Purnell PhD, Roland J. Thorpe Jr. PhD, Deidra C. Crews MD ScM, Sarah L. Szanton PhD, Dorry L. Segev MD PhD, Mara McAdams-DeMarco PhD
-
Human Factors Contributing to Infection Prevention in Outpatient Hemodialysis Centers: A Mixed Methods Study Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-03-04 Sarah Henrickson Parker, Matthew N. Jesso, Laurie D. Wolf, Kerry Avondet Leigh, Stephanie Booth, Nicole Gualandi, Renee E. Garrick, Alan S. Kliger, Priti R. Patel
Infection prevention efforts in dialysis centers can avert patient morbidity and mortality but are challenging to implement. The objective of this study was to better understand how the design of the work system might contribute to infection prevention in outpatient dialysis centers. Mixed methods, observational study. Six dialysis facilities across the United States visited by a multidisciplinary
-
Use of Immunoadsorption and Plasma Exchange for Treating Anti–Glomerular Basement Membrane Disease: Clinical Experience in Germany Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-03-01 Friedrich A. von Samson-Himmelstjerna MD, Nassim Kakavand MD, Jakob C. Voran MD, Benedikt Kolbrink MD, Kevin Schulte MD
-
Hot Spot of Complement Factor I Rare Variant p.Ile357Met in Patients With Hemolytic Uremic Syndrome Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-02-28 Nora Schwotzer, Fadi Fakhouri, Paula Vieira Martins, Yahsou Delmas, Sophie Caillard, Julien Zuber, Olivier Moranne, Laurent Mesnard, Véronique Frémeaux-Bacchi, Carine El-Sissy
Atypical hemolytic uremic syndrome (aHUS) is a rare kidney disease due to a dysregulation of the complement alternative pathway. Complement factor I (CFI) negatively regulates the alternative pathway and gene rare variants have been associated to aHUS with a low disease penetrance. We report 10 unrelated cases of HUS associated to a rare variant, p.Ile357Met (c.1071T>G). All patients with isolated
-
-
-
Designing an Implementable Clinical Prediction Model for Near-Term Mortality and Long-Term Survival in Patients on Maintenance Hemodialysis Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-02-21 Benjamin A. Goldstein, Chun Xu, Jonathan Wilson, Ricardo Henao, Patti L. Ephraim, Daniel E. Weiner, Tariq Shafi, Julia J. Scialla
The life expectancy of patients treated with maintenance hemodialysis (MHD) is heterogeneous. Knowledge of life-expectancy may focus care decisions on near-term versus long-term goals. The current tools are limited and focus on near-term mortality. Here, we develop and assess potential utility for predicting near-term mortality and long-term survival on MHD. Predictive modeling study. 42,351 patients
-
-
-
-
An Unusual Case of Bone Pain, Hypophosphatemia, and a Gastric Mass: A Quiz Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-02-21 Xiang Li, Dongsheng Cheng, Zhenkui Sun, Qiong Jiao, Chun Wang, Ying Fan
-
Magnesium Disorders: Core Curriculum 2024 Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-02-17 Emmanuel A. Adomako, Alan S.L. Yu
Magnesium is ubiquitous in nature. It sits at the origin of the food chain, occupying the center of chlorophyl in plants. In humans, magnesium is critical to diverse molecular and catalytic processes, including energy transfer and maintenance of the genome. Despite its abundance, hypomagnesemia is common and often goes undiagnosed. This is in spite of epidemiologic data linking low magnesium with chronic
-
-
Sodium/Glucose Cotransporter 2 Inhibitors and Magnesium Homeostasis: A Review Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-02-17 Chintan V. Shah, Matthew A. Sparks, Chien-Te Lee
Magnesium (Mg), also known as “the forgotten ion,” is the second most abundant intracellular cation and is essential in a broad range of intracellular physiological and biochemical reactions. Its deficiency, hypomagnesemia (Mg<1.8mg/dL), is a prevalent condition and routinely poses challenges in its management in clinical practice. Sodium/glucose cotransporter 2 (SGLT2) inhibitors have emerged as a
-
Time-Varying Proteinuria and Progression of IgA Nephropathy: A Cohort Study Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-02-15 Chen Tang, Pei Chen, Feng-Lei Si, Ji-Cheng Lv, Su-Fang Shi, Xu-Jie Zhou, Li-Jun Liu, Hong Zhang
-
Dialysis Catheter Tip Design and Dysfunction: An Unsolved Challenge Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-02-15 Pallavi Prasad, Tushar J. Vachharajani
-
Continuous Kidney Replacement Therapy and Survival in Children and Young Adults: Findings From the Multinational WE-ROCK Collaborative Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-02-15 Michelle C. Starr, Katja M. Gist, Huaiyu Zang, Nicholas J. Ollberding, Shanthi Balani, Andrea Cappoli, Eileen Ciccia, Catherine Joseph, Aadil Kakajiwala, Aaron Kessel, Melissa Muff-Luett, María J. Santiago Lozano, Matthew Pinto, Stephanie Reynaud, Sonia Solomon, Cara Slagle, Rachana Srivastava, Weiwen V. Shih, Tennille Webb, Shina Menon, Worldwide Exploration of Renal Replacement Outcomes Collaborative
-
APOL1 Nephropathy Risk Variants Through the Life Course: A Review Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-02-09 Ai Itoku, Jaya Isaac, Scott Wilson, Kimberly Reidy, Frederick Kaskel
Two variant alleles of the gene apolipoprotein L1 (), known as risk variants (RVs), are a major contributor to kidney disease burden in those of African descent. The protein contributes to innate immunity and may protect against , HIV, , and leishmaniasis. However, the effects of carrying 1 or more RVs contribute to a variety of disease processes starting as early as in utero and can be exacerbated
-
A “Fit for Purpose” Approach to CKD Classification? Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-02-01 Jin Ho Hwang, Chi-yuan Hsu
Abstract not available
-
How Much Patient Autonomy Is Too Much? Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-01-30 Chia-Ter Chao MD
Abstract not available
-
Aptamer-Based Proteomics in CKD Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-01-27 Taesoo Kim, Eugene P. Rhee
Abstract not available
-
Association of Kidney Cysts With Progressive CKD After Radical Nephrectomy Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-01-26 Moldovan Sabov, Aleksandar Denic, Aidan F. Mullan, Anthony C. Luehrs, Timothy L. Kline, Bradley J. Erickson, Theodora A. Potretzke, R. Houston Thompson, Vidit Sharma, Peter C. Harris, Andrew D. Rule
Rationale & Objective Simple kidney cysts are common and usually considered of limited clinical relevance. They are associated with older age and lower glomerular filtration rate (GFR), but little is known of their association with progressive chronic kidney disease (CKD) which was the focus of this study. Study Design Observational cohort study. Setting & Participants Patients with pre-surgical CT
-
Potentially Inappropriately Medication Prescriptions Among Medicare Patients Receiving Hemodialysis Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-01-23 Armando Silva Almodovar, Macarius Donneyong, Eric Seiber, Milap C. Nahata
Abstract not available
-
Reducing Elevated Parathyroid Hormone to Protect Bone Strength in End-Stage Kidney Disease Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-01-25 Tamara Isakova, Thomas L. Nickolas
Abstract not available
-
Improvements in Kidney Outcomes Over the Years: Reason for Optimism but a Challenge for Trialists Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-01-23 Doreen Zhu, Parminder K. Judge, Richard Haynes
Abstract not available
-
Metabolites Associated With Uremic Symptoms in Patients With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-01-23 Kendra E. Wulczyn, Tariq Shafi, Amanda Anderson, Hernan Rincon-Choles, Clary B. Clish, Michelle Denburg, Harold I. Feldman, Jiang He, Chi-yuan Hsu, Tanika Kelly, Paul L. Kimmel, Rupal Mehta, Robert G. Nelson, Vasan Ramachandran, Ana Ricardo, Vallabh O. Shah, Anand Srivastava, Dawei Xie, Eugene P. Rhee, Sahir Kalim, CRIC Study Investigators, Laura M. Dember MD, J. Richard Landis PhD, Raymond R. Townsend
-
Monoclonal Immunoglobulin Crystalline Membranous Nephropathy Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-01-23 Salvatore E. Mignano, Virginie Pascal, Nnaemezie E. Odioemene, William Forehand, Vincent Javaugue, Samar M. Said, Sanjeev Sethi, Christophe Sirac, Samih H. Nasr
-
Quantity Versus Quality of Anti–Phospholipase A2 Receptor 1 Autoantibodies in the Assessment of Clinical Outcome in Membranous Nephropathy: The Debate Continues Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-01-22 Laurence H. Beck Jr.
Abstract not available
-
-
Implantation Biopsy in Living-Donor Kidney Transplantation: Expectations, Utility, and Limitations Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-01-20 Junji Yamauchi, Isaac E. Hall, Divya Raghavan
Abstract not available
-
-
-
-
Rapidly Rising Serum Creatinine in a Patient With Colorectal Adenocarcinoma and Eosinophilia: A Quiz Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-01-19 Athiphat Banjongjit, Vorachai Ratanatharathorn, Piyanut Mahanupap, Winyou Mitarnun
Abstract not available
-
Toxic Nephropathies of the Tubulointerstitium: Core Curriculum 2024 Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-01-19 Namrata Krishnan, Dennis G. Moledina, Mark A. Perazella
Toxic nephropathies are a clinically common group of disorders characterized by toxin-induced renal injury that can affect the glomerulus, vasculature, or tubulointerstitium. Various endogenous (eg, myoglobin, hemoglobin, monoclonal light chains, and lysozymes) and exogenous toxins (eg, therapeutic drugs, herbal medications, heavy metals, radiocontrast, intoxicants, and environmental exposures) have
-
Anticoagulation for Atrial Fibrillation in Advanced CKD: Can Observational Studies Provide the Answer? Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-01-17 Daniel E. Weiner, Mark J. Sarnak
Abstract not available
-
Navigating Living Kidney Donation and Transplantation Among South Asian Canadians: The ACTION Project Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-01-18 Reetinder Kaur, Kara Schick-Makaroff, Phuc Dang, Ayumi Sasaki, Paula Neves, Istvan Mucsi, Jagbir Gill
-
Cystatin C to Creatinine Ratio and Measured GFR in Hospitalized Older Adults Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-01-13 Morten Baltzer Houlind, Ove Andersen, Esben Iversen
Abstract not available
-
In Reply to “Cystatin C to Creatinine Ratio and Measured GFR in Hospitalized Older Adults” Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-01-13 Anders O. Grubb, Anna Åkesson, Anders Christensson
Abstract not available
-
Patients’ Perspectives on Health-Related Social Needs and Recommendations for Interventions: A Qualitative Study Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-01-11 Tessa K. Novick, Michelle Osuna, Caroline Emery, Francisco Barrios, Daniel Ramirez, Deidra C. Crews, Elizabeth A. Jacobs
Rationale & Objective People with low socioeconomic status are disproportionately affected by kidney failure, and their adverse outcomes may stem from unmet health-related social needs. This study explored hemodialysis patient perspectives on health-related social needs and recommendations for intervention. Study Design Qualitative study using semi-structured interviews. Settings & Participants Thirty-two
-
Challenges to Informed, Patient-Centered, and Shared Decision Making for Treatment of Kidney Failure in Older Adults Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-01-11 Elizabeth Kiernan, Susan P.Y. Wong
Abstract not available
-
A Deep Intronic PKHD1 Variant Identified by SpliceAI in a Deceased Neonate With Autosomal Recessive Polycystic Kidney Disease Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-01-10 Felix Richter, Kayleigh D. Rutherford, Anisha J. Cooke, Malorie Meshkati, Vanessa Eddy-Abrams, Daniel Greene, Jordana Kosowsky, Yeaji Park, Surabhi Aggarwal, Rebecca J. Burke, Weili Chang, Jillian Connors, Peter J. Giannone, Thomas Hays, Divya Khattar, Mark Polak, Liana Senaldi, Matthew Smith-Raska, Shanthy Sridhar, Laurie Steiner, Ernest Turro
The etiologies of newborn deaths in neonatal intensive care units usually remain unknown, even following genetic testing. Whole-genome sequencing, combined with artificial intelligence-based methods for predicting the effects of non-coding variants, provide an avenue for resolving these deaths. Using one such method, SpliceAI, we identified a maternally inherited deep intronic PKHD1 splice variant
-
Hospital Garden Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-01-10 Tarek Zieneldien BS
Abstract not available
-
Chronic Hyponatremia and Brain Structure and Function Before and After Treatment Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-01-04 Victor Suárez, Rosanne Picotin, Ronja Faßbender, Hannes Gramespacher, Stefan Haneder, Thorsten Persigehl, Polina Todorova, Matthias Johannes Hackl, Oezguer A. Onur, Nils Richter, Volker Burst
Rationale & Objective Hyponatremia is the most common electrolyte disorder and is associated with significant morbidity and mortality. This study investigated neurocognitive impairment, brain volume, and alterations in MRI-based measures of cerebral function in patients before and after treatment for hyponatremia. Study Design Prospective cohort study. Setting & Participants Patients with presumed
-
Difference Between Estimated GFR Based on Cystatin C Versus Creatinine and Incident Atrial Fibrillation: A Cohort Study of the UK Biobank Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-01-01 Ga Young Heo, Hee Byung Koh, Chan-Young Jung, Jung Tak Park, Seung Hyeok Han, Tae-Hyun Yoo, Shin-Wook Kang, Hyung Woo Kim
Rationale & Objective The difference between cystatin C-based and creatinine-based estimated glomerular filtration rate (eGFRdiff) has been suggested to reflect factors distinct from kidney function that are associated with cardiovascular risk. However, the association between eGFRdiff and atrial fibrillation (AF) risk has not been extensively evaluated. Study Design Prospective cohort study. Setting
-
Atypical Anti-Glomerular Basement Membrane Nephritis: A Case Series From the French Nephropathology Group Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-01-01 Bertrand Chauveau, Jean-Baptiste Gibier, Jérôme Olagne, Antoine Morel, Selda Aydin, Stephen P. McAdoo, Nicolas Viallet, Hélène Perrochia, Emilie Pambrun, Virginie Royal, Nathalie Demoulin, Jean-Louis Kemeny, Carole Philipponnet, Alexandre Hertig, Jean-Jacques Boffa, Emmanuelle Plaisier, Camille Domenger, Isabelle Brochériou, Clément Deltombe, Jean-Paul Duong Van Huyen, Vincent Vuiblet
Rationale & Objective Atypical anti-glomerular basement membrane (GBM) nephritis is characterized by a bright linear immunoglobulin staining along the GBM by immunofluorescence without a diffuse crescentic glomerulonephritis nor serum anti-GBM antibodies by conventional ELISA. We characterized a series of patients with atypical anti-GBM disease. Study Design Case series. Setting & Participants Patients
-
Infections Following Kidney Transplantation After Exposure to Immunosuppression for Treatment of Glomerulonephritis Am. J. Kidney Dis. (IF 13.2) Pub Date : 2023-12-30 David Massicotte-Azarniouch, Randal K. Detwiler, Yichun Hu, Ronald J. Falk, Manish K. Saha, David van Duin, Susan L. Hogan, Vimal K. Derebail
Rationale & Objective Kidney transplant patients with glomerulonephritis (GN) as their native disease commonly have received pre-transplant immunosuppression (PTI). This may contribute to the immunosuppression burden potentially increasing the risk for infections following transplantation. Study Design Single-center, retrospective cohort study. Setting & Participants: Recipients of a kidney transplant
-
Diabetes Insipidus in Deceased Donors and Outcomes in Kidney Transplant Recipients Am. J. Kidney Dis. (IF 13.2) Pub Date : 2023-12-30 Miguel Nunez, James Gardner, Shareef Syed, Allison Webber, Jun Shoji, Timothy P. Copeland, Charles E. McCulloch, Elaine Ku, Garrett R. Roll
Abstract not available